# Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer

> **NCT01199393** · — · COMPLETED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 153 (actual)

## Conditions studied

- Breast Neoplasm
- Drug Therapy
- Polymorphism,Single Nucleotide

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01199393
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-12
- **Final completion:** 2015-05
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01199393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01199393, "Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01199393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*